| Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity M Capello, JV Vykoukal, H Katayama, LE Bantis, H Wang, DL Kundnani, ... Nature communications 10 (1), 254, 2019 | 141 | 2019 |
| Sequential validation of blood-based protein biomarker candidates for early-stage pancreatic cancer M Capello, LE Bantis, G Scelo, Y Zhao, P Li, DS Dhillon, NJ Patel, ... JNCI: Journal of the National Cancer Institute 109 (4), djw266, 2017 | 132 | 2017 |
| Sequential validation of blood-based protein biomarker candidates for early-stage pancreatic cancer M Capello, LE Bantis, G Scelo, Y Zhao, P Li, DS Dhillon, NJ Patel, ... JNCI: Journal of the National Cancer Institute 109 (4), djw266, 2017 | 132 | 2017 |
| Assessment of lung cancer risk on the basis of a biomarker panel of circulating proteins F Guida, N Sun, LE Bantis, DC Muller, P Li, A Taguchi, D Dhillon, ... JAMA oncology 4 (10), e182078-e182078, 2018 | 105 | 2018 |
| Role of CPS1 in cell growth, metabolism, and prognosis in LKB1-inactivated lung adenocarcinoma M Çeliktaş, I Tanaka, S Chandra Tripathi, JF Fahrmann, ... Journal of the National Cancer Institute 109 (3), djw231, 2017 | 80 | 2017 |
| SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1–Negative Lung Adenocarcinomas I Tanaka, D Dayde, MC Tai, H Mori, LM Solis, SC Tripathi, JF Fahrmann, ... JNCI: Journal of the National Cancer Institute 114 (2), 290-301, 2022 | 20 | 2022 |
| and the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Consortium for Early Detection of Lung Cancer. Assessment of Lung Cancer Risk on the Basis of a … F Guida, N Sun, LE Bantis, DC Muller, P Li, A Taguchi, D Dhillon, ... JAMA Oncol 4 (10), e182078, 2018 | 9 | 2018 |
| HIV infection and circulating levels of prosurfactant protein B and surfactant protein D MS Shiels, GD Kirk, MB Drummond, D Dhillon, SM Hanash, A Taguchi, ... The Journal of Infectious Diseases 217 (3), 413-417, 2018 | 8 | 2018 |
| Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity. Nat Commun. 2019; 10 (1): 254 M Capello, JV Vykoukal, H Katayama, LE Bantis, H Wang, DL Kundnani Epub 2019/01/18, 2019 | 4 | 2019 |
| CPS1 as a therapeutic target and prognostic indicator in LKB1-inactivated lung adenocarcinoma M Celiktas, I Tanaka, SC Tripathi, JF Fahrmann, C Aguilar-Bonavides, ... Cancer Research 77 (13_Supplement), 2775-2775, 2017 | | 2017 |
| Abstract LB-134: Sequential validation of blood-based protein biomarker candidates for early-stage pancreatic cancer M Capello, LE Bantis, G Scelo, Y Zhao, DS Dhillon, H Wang, ... Cancer Research 76 (14_Supplement), LB-134-LB-134, 2016 | | 2016 |
